2024
Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer
Nagpal S, Milano M, Chiang V, Soltys S, Brackett A, Halasz L, Garg A, Sahgal A, Ahluwalia M, Tom M, Palmer J, Knisley J, Chao S, Gephart M, Wang T, Lo S, Chang E. Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer. Neuro-Oncology 2024, 26: 1195-1212. PMID: 38459978, PMCID: PMC11226873, DOI: 10.1093/neuonc/noae041.Peer-Reviewed Original ResearchNon-small cell lung cancerTyrosine kinase inhibitorsCell lung cancerCentral nervous systemAmerican Radium SocietyALK-fusionBrain metastasesAmerican Radium Society Appropriate Use CriteriaLung cancerSequence of tyrosine kinase inhibitorsALK tyrosine kinase inhibitorsTreatment of brain metastasesEGFR tyrosine kinase inhibitorsWhole-brain RTEpidermal growth factor receptorGrowth factor receptorAppropriate Use CriteriaBrain RTEGFR-mutantRadiotherapyTreatment optionsFactor receptorKinase inhibitorsNervous systemLiterature search
2014
Mass Effect
Chiang V, Awad I. Mass Effect. 2014, 1007-1008. DOI: 10.1016/b978-0-12-385157-4.00765-x.Peer-Reviewed Original ResearchMass effectSuch mass lesionsDisturbance of consciousnessTreatment of choiceCompression of vesselsCentral nervous systemCerebrospinal fluid flowSecondary hydrocephalusVisual obscurationsMass lesionSurgical removalVascular lesionsGeneral symptomsIntracranial pressureExtrinsic pathologiesSpecific symptomsNervous systemNeuronal tissueLesionsSymptomsPossible obstructionFocal distortionVomitingHematomaIschemia